Core Laboratories reports Q3 2026 results in line with market expectations
Core Laboratories posted Q3 2026 revenue of $132.1 million and adjusted EPS of $0.16, both matching analyst consensus, according to StockStory.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Oilfield services provider Core Laboratories reported third-quarter 2026 revenue of $132.1 million, matching the consensus estimate compiled by S&P analysts. Revenue still fell 1.8% from a year earlier. Adjusted earnings per share came in at $0.16, also in line with forecasts.
The operating margin narrowed to 9.1% from 11.9% a year earlier, and the free cash flow margin dropped to 1.3% from 4.1%. The company's market capitalization stands at $474 million. According to StockStory, the shares fell 3.7% to $10.12 following the release.
why it matters
The report concerns a narrow segment of energy services, so its reach beyond the sector is limited. For investors in oilfield services, demand for drilling and contractor utilization matter more, while the weaker cash margin points to pressure on profitability across the group.
tags
instruments
sources
- Core Laboratories (NYSE:CLB) reports Q3 2026 in line with expectations — stockstory.org, 28 October 2026 at 21:02 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗